The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs

COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs. Critically ill patients are easily complicated by cytokine storms, acute respiratory distress syndrome (ARDS), and respiratory failure, which seriously threaten their lives. Pulmonary fibrosis (PF) is a common inter...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hao Shen, Nu Zhang, Yuqing Liu, Xuerong Yang, Yuanyuan He, Qi Li, Xiaoyan Shen, Yulian Zhu, Yong Yang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Pharmacology
Assuntos:	pulmonary fibrosis COVID-19 mechanism interaction drug treatment
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fphar.2021.805535/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!